These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25651030)

  • 1. Angiotensin II receptor blocker prevents upper gastrointestinal bleeding in hypertensive patients with chronic kidney disease not on dialysis.
    Chou CY; Wang SM; Chang PH; Kuo HL; Chang CT; Liu JH; Wang IK; Yang YF; Liang CC; Huang CC
    Int J Clin Pract; 2015 Jul; 69(7):722-8. PubMed ID: 25651030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.
    Hsu TW; Liu JS; Hung SC; Kuo KL; Chang YK; Chen YC; Hsu CC; Tarng DC
    JAMA Intern Med; 2014 Mar; 174(3):347-54. PubMed ID: 24343093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term risk of upper gastrointestinal hemorrhage after advanced AKI.
    Wu PC; Wu CJ; Lin CJ; Wu VC;
    Clin J Am Soc Nephrol; 2015 Mar; 10(3):353-62. PubMed ID: 25527706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
    Wu LS; Chang SH; Chang GJ; Liu JR; Chan YH; Lee HF; Wen MS; Chen WJ; Yeh YH; Kuo CT; See LC
    Cardiovasc Diabetol; 2016 Apr; 15():56. PubMed ID: 27039185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upper gastrointestinal bleeding as a risk factor for dialysis and all-cause mortality: a cohort study of chronic kidney disease patients in Taiwan.
    Liang CC; Chou CY; Chang CT; Wang IK; Huang CC
    BMJ Open; 2016 May; 6(5):e010439. PubMed ID: 27150184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of low-dose proton pump inhibitor on preventing upper gastrointestinal bleeding in chronic kidney disease patients receiving aspirin.
    Lim H; Kim JH; Baik GH; Park JW; Kang HS; Moon SH; Park CK
    J Gastroenterol Hepatol; 2015 Mar; 30(3):478-84. PubMed ID: 25252119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An angiotensin II receptor blocker-calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone.
    Kim-Mitsuyama S; Ogawa H; Matsui K; Jinnouchi T; Jinnouchi H; Arakawa K
    Kidney Int; 2013 Jan; 83(1):167-76. PubMed ID: 23051740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-hospital mortality risk estimation in patients with acute nonvariceal upper gastrointestinal bleeding undergoing hemodialysis: a retrospective cohort study.
    Weng SC; Shu KH; Tarng DC; Tang YJ; Cheng CH; Chen CH; Yu TM; Chuang YW; Huang ST; Sheu WH; Wu MJ
    Ren Fail; 2013; 35(2):243-8. PubMed ID: 23336331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton-pump inhibitors for prevention of upper gastrointestinal bleeding in patients undergoing dialysis.
    Song YR; Kim HJ; Kim JK; Kim SG; Kim SE
    World J Gastroenterol; 2015 Apr; 21(16):4919-24. PubMed ID: 25945005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upper gastrointestinal bleeding in patients with CKD.
    Liang CC; Wang SM; Kuo HL; Chang CT; Liu JH; Lin HH; Wang IK; Yang YF; Lu YJ; Chou CY; Huang CC
    Clin J Am Soc Nephrol; 2014 Aug; 9(8):1354-9. PubMed ID: 24903385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction.
    Evans M; Carrero JJ; Szummer K; Åkerblom A; Edfors R; Spaak J; Jacobson SH; Andell P; Lindhagen L; Jernberg T
    J Am Coll Cardiol; 2016 Apr; 67(14):1687-97. PubMed ID: 27056774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors for Upper Gastrointestinal Bleeding in Patients Taking Selective COX-2 Inhibitors: A Nationwide Population-Based Cohort Study.
    Lin XH; Young SH; Luo JC; Peng YL; Chen PH; Lin CC; Chen WM; Hou MC; Lee FY
    Pain Med; 2018 Feb; 19(2):225-231. PubMed ID: 28460044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors for clinically significant upper gastrointestinal bleeding in patients with severe acute pancreatitis.
    Zhan XB; Guo XR; Yang J; Li J; Li ZS
    J Dig Dis; 2015 Jan; 16(1):37-42. PubMed ID: 25346469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineral Metabolites, Angiotensin II Inhibition and Outcomes in Advanced Chronic Kidney Disease.
    Jovanovich AJ; Chonchol MB; Sobhi A; Kendrick JB; Cheung AK; Kaufman JS; Smits G; Jablonski KL;
    Am J Nephrol; 2015; 42(5):361-8. PubMed ID: 26606453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteinuria as a risk marker for the progression of chronic kidney disease in patients on predialysis care and the role of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment.
    de Goeij MC; Liem M; de Jager DJ; Voormolen N; Sijpkens YW; Rotmans JI; Boeschoten EW; Dekker FW; Grootendorst DC; Halbesma N;
    Nephron Clin Pract; 2012; 121(1-2):c73-82. PubMed ID: 23128440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of multidisciplinary care for chronic kidney disease in Taiwan: a 3-year prospective cohort study.
    Chen YR; Yang Y; Wang SC; Chiu PF; Chou WY; Lin CY; Chang JM; Chen TW; Ferng SH; Lin CL
    Nephrol Dial Transplant; 2013 Mar; 28(3):671-82. PubMed ID: 23223224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness of olmesartan and other angiotensin receptor blockers in diabetes mellitus: retrospective cohort study.
    Padwal R; Lin M; Etminan M; Eurich DT
    Hypertension; 2014 May; 63(5):977-83. PubMed ID: 24535009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease.
    Chen PM; Lai TS; Chen PY; Lai CF; Wu V; Chiang WC; Chen YM; Wu KD; Tsai TJ
    J Formos Med Assoc; 2014 Apr; 113(4):219-26. PubMed ID: 24512756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of urine urea nitrogen and protein intake adjusted by using the estimated urine creatinine excretion rate on the antiproteinuric effect of angiotensin II type I receptor blockers.
    Chin HJ; Kim DK; Park JH; Shin SJ; Lee SH; Choi BS; Kim S; Lim CS
    Nutrition; 2015; 31(11-12):1333-8. PubMed ID: 26304595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin receptor blocker and calcium channel blocker combination prevents cardiovascular events in CKD better than high-dose ARB alone.
    Woo KT; Wong KS; Choong HL; Foo MW; Tan HK; Chan CM
    Kidney Int; 2013 Jul; 84(1):214-5. PubMed ID: 23812366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.